Palantir Technologies Inc. (PLTR) Stock Analysis & DCF Valuation

Palantir Technologies Inc. logo

PLTR · NYSE ·

Sell

High confidence

Palantir provides enterprise data analytics software. Sentiment is mixed following recent earnings, focusing on commercial growth acceleration.

Palantir Technologies Inc. Intrinsic Value & DCF Valuation

Our discounted cash flow (DCF) model estimates Palantir Technologies Inc. fair value at $NaN per share, compared to the current market price of $NaN. This implies -91.5% downside from today's price.

Fair Value (DCF) $NaN
Current Market Price $NaN
Upside / Downside -91.5%

PLTR Key Financial Metrics

Market Cap $53.27 Billion
P/E Ratio 144.32
Dividend Yield 0.00%
Analyst Target Price $23.78

Palantir Technologies Inc. Long-Term Stock Outlook

Palantir is strategically positioned to capitalize on the enterprise AI spending boom, driven by its established government base and growing commercial adoption of Foundry.

Bullish Factors

  • [object Object]
  • [object Object]
  • [object Object]

Key Risks

  • [object Object]
  • [object Object]
  • [object Object]

PLTR Analyst Sentiment & Market Consensus

Analyst sentiment remains cautious to positive following Q1 2026 earnings. Consensus leans towards 'Hold' to 'Buy', praising profitability but cautioning on valuation.

Should You Buy PLTR Stock?

Recommendation: Sell High confidence

No recommendation provided

Frequently Asked Questions

Is PLTR a good stock to buy?

Based on our AI analysis, Palantir Technologies Inc. (PLTR) is rated as Sell with high confidence. Palantir provides enterprise data analytics software. Sentiment is mixed following recent earnings, focusing on commercial growth acceleration.

What is PLTR stock price target?

Our DCF valuation model estimates Palantir Technologies Inc. (PLTR) fair value at $NaN, suggesting -91.5% downside potential from current price of $NaN.

What is PLTR fair value?

The fair value for Palantir Technologies Inc. (PLTR) is estimated at $NaN based on discounted cash flow (DCF) analysis. This represents -91.5% downside from the current price.

*This analysis is for informational purposes only and should not be taken as financial advice.*

© 2025 stockpickr - AI-Powered Stock Analysis

View more stock analyses